Prohibitin in breast cancer cell lines: Loss of antiproliferative activity is linked to 3' untranslated region mutations

Cell Growth and Differentiation

Volumn 7, Issue 7, 1996, Pages 871-878

  Jupe, Eldon R ^a   Liu, Xiao Tie ^a   Kiehlbauch, Julie L ^a   Keith McClung, J ^a   Dell'Orco, Robert T ^a  

^a OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELE; AMINO ACID SEQUENCE; ARTICLE; BREAST CANCER; CANCER CELL; CELL IMMORTALIZATION; CELL PROLIFERATION; CHROMOSOME 17Q; GENE LOCATION; GENE MUTATION; GENETIC COMPLEMENTATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; RNA TRANSLATION; TUMOR SUPPRESSOR GENE;

ALLELES; BREAST NEOPLASMS; CELL DIVISION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LINKAGE (GENETICS); MUTATION; PROTEINS; REPRESSOR PROTEINS; TUMOR CELLS, CULTURED;

EID: 0029801945     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. McClung, J. K., Danner, D. B., Stewart, D. A., Smith, J. R., Schneider, E. L., Lumpkin, C. K., Dell'Orco, R. T., and Nuell, M. J. Isolation of a cDNA that hybrid selects antiproliferative mRNA from rat liver. Biochem. Biophys. Res. Commun., 164: 1316-1322, 1989.
2. Nuell, M. J., Stewart, D. A., Walker, L., Friedman, V., Wood, C. A., Owens, G. A., Smith, J. R., Schneider, E. L., Dell'Orco, R. T., Lumpkin, C. K., Danner, D. B., and McClung, J. K. Prohibitin, an evolutionary conserved intracellular protein that blocks DNA synthesis in normal fibroblasts and HeLa cells. Mol. Cell. Biol., 11: 1372-1381, 1991.
3. Jupe, E., Liu, X-T., Kiehlbauch, J. L., McClung, J. K., and Dell'Orco, R. T. Prohibitin antiproliferative activity and lack of heterozygosity in immortalized cell lines. Exp. Cell Res., 278: 577-580, 1995.
4. Jupe, E., Liu, X-T., Kiehlbauch, J. L., McClung, J. K., and Dell'Orco, R. T. The 3′ untranslated region of prohibitin and cellular immortalization. Exp. Cell Res., 224: 128-135, 1996.
5. Terashima, M., Kim, K-M., Adachi, T., Nielsen, P. J., Reth, M., Kohler, G., and Lamers, M. C. The lgM antigen receptor of B lymphocytes is associated with prohibitin and a prohibitin-related protein. EMBO J., 13: 3782-3792, 1994.
6. Eveleth, D. D. J., and Marsh, J. L. Sequence and expression of the Cc gene, a member of the dopa decarboxylase gene cluster of Drosophila: possible translational regulation. Nucleic Acids Res., 14: 6169-6183, 1986.
7. Franklin, D. S., and Jazwinski, S. M. A yeast homolog of the rat prohibitin gene is differentially expressed and determines longevity in Saccharomyces cerevisiae. J. Cell. Biochem. Suppl., 17D: 159, 1993.
8. McClung, J. K., Jupe, E. R., Liu, X-T., and Dell'Orco, R. T. Prohibitin: potential role in senescence, development, and tumor suppression. Exp. Gerontol., 30: 99-124, 1995.
9. Pereira-Smith, O. M., and Smith, J. R. Evidence for the recessive nature of cellular immortality. Science (Washington DC), 221: 964-966, 1983.
10. Pereira-Smith, O. M., and Smith, J. R. Genetic analysis of indefinite division in human cells: identification of four complementation groups. Proc. Natl. Acad. Sci. USA, 85: 6042-6046, 1988.
11. Sager, R. Tumor suppressor genes: the puzzle and the promise. Science (Washington DC), 246: 1406-1412, 1989.
12. Smith, J. R. Inhibitors of DNA synthesis derived from senescent human diploid fibroblasts. Exp. Gerontol., 27: 409-412, 1992.
13. Rastinejad, F., and Blau, H. M. Genetic complementation reveals a novel regulatory role for 3′untranslated regions in growth and differentiation. Cell, 72: 903-917, 1993.
14. Rastinejad, F., Conboy, M. J., Rando, T. A., and Blau, H. M. Tumor suppression by RNA from the 3′untranslated region of α-tropomyosin. Cell, 75: 1107-1117, 1993.
15. White, J. J., Ledbetter, D. H., Eddy, R. L., Jr., Shows, T. B., Stewart, D. A., Nuell, M. J., Friedman, V., Wood, C. M., Owens, G. A., McClung, J. K., Danner, D. B., and Morton, C. C. Assignment of the human prohibitin gene (PHB) to chromosome 17 and identification of a DNA polymorphism. Genomics, 11: 228-230, 1991.
16. Black, D. M., Nicolai, H., Borrow, J., and Solomon, E. A somatic cell hybrid map of the long arm of human chromosome 17, containing the familial breast cancer locus (BRCA1). Am. J. Hum. Genet., 52: 702-710, 1993.
17. Nagai, M. A., Yamamoto, L., Salaorni, S., Pacheco, M. M., Bretani, M. M., Barbosa, E. M., Brentani, R. R., Mazoyer, S., Smith, S. A., Ponder, B. A. J., and Mulligan, L. M. Detailed deletion mapping of chromosome segment 17q 12-21 in sporadic breast tumors. Genes, Chromosomes & Cancer., 11: 58-62, 1994.
18. Black, D., and Solomon, E. The search for the familial breast/ovarian cancer gene. Trends Genet., 9: 22-26, 1993.
19. Miki, Y., Swensen, J., Shattuck-Eidens, D., Futreal, P. A., Harshman, K., Tavtigian, S., Liu, Q., Cochran, C., Bennett, M., Ding, W., Bell, R., Rosenthal, J., Hussey, C., Tran, T., McClure, M., Frye, C., Hattier, T., Phelps, R., Haugen-Strano, A., Katcher, H., Yakumo, K., Gholami, Z., Schaffer, D., Stone, S., Bayer, S., Wray, C., Bogden, R., Dayananth, P., Ward, J., Tonin, P., Narod, S., Bristow, P. K., Norris, F. H., Helvering, L., Morrison, P., Rosteck, P., Lai, M., Barret, J. C., Lewis, C., Neuhausen, S., Cannon-Albright, L., Goldgar, D., Wiseman, R., Kamb, A., and Skolnick, M. H. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science (Washington DC), 266: 66-71, 1994.
20. Sato, T., Saito, H., Swensen, J., Olifant, A., Wood, C., Danner, D., Sakamoto, T., Takita, K., Kasumi, F., Miki, Y., Skolnick, M., and Nakamura, Y. The human prohibitin gene located on chromosome 17q21 is mutated in sporadic breast cancer. Cancer Res., 52: 1643-1646, 1992.
21. Futreal, P. A., Liu, Q., Shattuck-Eidens, D., Cochran, C., Harshman, K., Tavtigian, S., Bennett, L. M., Haugen-Strano, A., Swensen, J., Miki, Y., Eddington, K., McClure, M., Frye, C., Weaver-Feldhaus, J., Ding, W., Gholami, Z., Soderkvist, P., Terry, L., Jhanwar, S., Berchuck, A., Iglehard, J. D., Marks, J., Ballinger, D. G., Barret, J. C., Skolnick, M. H., Kamb, A., and Wiseman, R. BRCA1 mutations in primary breast and ovarian carcinomas. Science (Washington DC), 266: 120-122, 1994.
22. Theile, M., Hartmann, S., Scherthan, H., Arnold, W., Deppert, W., Frege, R., Gaab, F., Haensch, W., and Scherneck, S. Suppression of tumorigenicity of breast carcer cells by transfer of human chromosome 17 does not require transferred BRCA1 and p53 genes. Oncogene, 10: 439-443, 1995.
23. Tokino, T., Davidson, N., Helzlsouer, K., Zehnbauer, B., Nakamura, Y., Vogelstein, B., and Sidransky, D. Absence of germline prohibitin mutations in early onset breast cancer. Int. J. Oncol., 3: 769-722, 1993.
24. Asamoto, M., and Cohen, S. M. Prohibitin gene is overexpressed but not mutated in rat bladder carcinomas and cell lines. Cancer Lett., 83: 201-207, 1994.
25. Cliby, W., Sarkar, G., Ritland, S. R., Hartmann, L., Podratz, K. C., and Jenkins, R. B. Absence of prohibitin gene mutations in human epithelial ovarian tumors. Gynecol. Oncol., 50: 34-37, 1994.
26. Ning, Y., Weber, J. L., Killary, A. M., Ledbetter, D. H., Smith, J. R., and Pereira-Smith, O. M. Genetic analysis of indefinite division in human cells: evidence for a cell senescence-related gene(s) on human chromosome 4. Proc. Natl. Acad. Sci. USA, 88: 55635-55639, 1991.
27. Ning, Y., Shay, J. W., Lovell, M., Taylor, L., Ledbetter, D. H., and Pereira-Smith, O. M. Tumor suppression by chromosome 11 is not due to cellular senescence. Exp. Cell Res., 192: 220-226, 1991.
28. Devilee, P., and Cornelisse, C. J. Somatic genetic changes in human breast cancer. Biochim. Biophys. Acta., 1198: 113-130, 1994.
29. Cox, L. A., Chen, G., and Lee, E. Y-H. P. Tumor suppressor genes and their role in breast cancer. Breast Cancer Res. Treat., 32: 19-38, 1994.
30. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., and Nakamura, Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50: 7184-7189, 1994.
31. Liu, X-T., Stewart, C. A., King, R. L., Danner, D. A., Dell'Orco, R. T., and McClung, J. K. Prohibitin expression during cellular senescence of human diploid fibroblasts. Biochem. Biophys. Res. Commun., 164: 409-414, 1994.
32. Chen, P-L, Chen, Y Bookstein, R., and Lee, W-H. Genetic mechanisms of tumor suppression by human p53 gene. Science (Washington DC), 250: 1576-1579, 1990.
33. Kupryjanczyk, J., Thor, A. D., Beauchamp, R., Merritt, V., Edgerton, S. M., Bell, D. A., and Yandell, D. W. p53 gene mutations and protein accumulation in human ovarian cancer. Proc. Natl. Acad. Sci. USA, 90: 4961-4965, 1993.
34. Crofts, F., Cosma, G. N., Currie, D., Taioli, E., Toniolo, P., and Garte, S. J. A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis (Lond.), 14: 1729-1731, 1993.
35. Crofts, F., Taioli, E., Trachman, J., Cosma, G. N., Currie, D., Toniolo, P., and Garte, S. J. Functional significance of different human CYP1A1 genotypes. Carcinogenesis (Lond.), 15: 2961-2963, 1994.
36. Taioli, E., Crofts, F., Trachman, J., Demopoulos, R., Toniolo, P., and Garte, S. J. A specific African-American CYP1A1 polymorphism is associated with adenocarcinoma of the lung. Cancer Res., 55: 472-473, 1995.
37. Stewart, C. A., and Dell'Orco, R. T. Expression of proliferating cell nuclear antigen during the cell cycle of human diploid fibroblasts. In Vitro Cell. Dev. Biol., 28A: 211-214, 1992.
38. 1 to multiple cell cycle by lovastatin. Cancer Res., 51: 3602-3609, 1991.
39. Altus, M. S., Wood, C. M., Stewart, D. A., Roskams, A. J. I., Friedman, V., Henderson, T., Owens, G. A., Danner, D. B., Jupe, E. R., Dell'Orco, R. T., and McClung, J. K. Regions of evolutionary conservation between rat and human prohibitin-encoding genes. Gene (Amst.), 158; 291-294, 1995.